Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Hepatology (Baltimore, Md.)
|
March 2, 2005
Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
Florian Graepler, Barbara Verbeek, Tilmann Graeter, et al.
International Journal of Cancer
|
June 26, 2013
Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses
Timo Weiland, Johanna Lampe, Frank Essmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2005
Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion
Sorin Armeanu, Michael Bitzer, Irina Smirnow, et al.
Molecular Therapy. Oncology
|
November 5, 2025
Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing
Maxim F Carle, Tahereh Mohammadian Gol, Justin S Antony, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Evidence for intercellular trafficking of VP22 in living cells
Marie-Luise Lemken, Claudia Wolf, Wolfgang A Wybranietz, et al.
Human Gene Therapy. Clinical Development
|
May 23, 2013
Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques
Iris Völker, Patricia Bach, Cheick Coulibaly, et al.
Cancer
|
April 5, 2007
Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma
Sascha Venturelli, Sorin Armeanu, Anita Pathil, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 2024
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients
Linus D Kloker, Mirjana Sidiras, Tim Flaadt, et al.
Journal of Hepatology
|
January 14, 2017
Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy
Thomas Klag, Julia Dietz, Christoph R Werner, et al.
Cytotechnology
|
January 22, 2010
Improved reproducibility in preparing precision-cut liver tissue slices
Martina Zimmermann, Johanna Lampe, Sebastian Lange, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Hepatology (Baltimore, Md.)
|
March 2, 2005
Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
Florian Graepler, Barbara Verbeek, Tilmann Graeter, et al.
International Journal of Cancer
|
June 26, 2013
Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses
Timo Weiland, Johanna Lampe, Frank Essmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2005
Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion
Sorin Armeanu, Michael Bitzer, Irina Smirnow, et al.
Molecular Therapy. Oncology
|
November 5, 2025
Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing
Maxim F Carle, Tahereh Mohammadian Gol, Justin S Antony, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Evidence for intercellular trafficking of VP22 in living cells
Marie-Luise Lemken, Claudia Wolf, Wolfgang A Wybranietz, et al.
Human Gene Therapy. Clinical Development
|
May 23, 2013
Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques
Iris Völker, Patricia Bach, Cheick Coulibaly, et al.
Cancer
|
April 5, 2007
Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma
Sascha Venturelli, Sorin Armeanu, Anita Pathil, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 2024
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients
Linus D Kloker, Mirjana Sidiras, Tim Flaadt, et al.
Journal of Hepatology
|
January 14, 2017
Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy
Thomas Klag, Julia Dietz, Christoph R Werner, et al.
Cytotechnology
|
January 22, 2010
Improved reproducibility in preparing precision-cut liver tissue slices
Martina Zimmermann, Johanna Lampe, Sebastian Lange, et al.
Page
of 15